Sign in

Andres Henao, MD PhD FIDSA

@andhen25.bsky.social
847 followers 1.5K following 28 posts

A US board-certified specialist in Infectious Diseases, with a focus on fungal and tropical infections | Universidad del Valle alumnus | Professor at CU Anschutz | Editor-in-Chief TAID | Associate Editor PLOSGPH | Global Health

PostsRepliesMedia
Reposted by Andres Henao, MD PhD FIDSA
The Lancet Microbe @lancetmicrobe.bsky.social · 25/08/2026
New research article Genomic diversity of #Trypanosoma cruzi clinical isolates: a retrospective analysis www.thelancet.com/journals/lan... #IDSky #ClinMicro #Chagas #OpenAccess #OA
023
Reposted by Andres Henao, MD PhD FIDSA
Madhu Pai, MD, PhD @madhupai.bsky.social · 26/06/2026
We could all use some good news these days Ghana cut malaria deaths by 86%!!! And they followed science and good public health policies healthpolicy-watch.news/how-ghana-sl...
healthpolicy-watch.news
How Ghana Slashed Child Malaria Deaths By 86% - Health Policy Watch
For decades, malaria has been one of Africa's most persistent health challenges. In Ghana, it was once the leading cause of death for children under five. Bed
6904256
Andres Henao, MD PhD FIDSA @andhen25.bsky.social · 08/06/2026
Check my piece @theconversation.com on infectious threats during the FIFA @worldcup.news in the USA, Mexico and Canada theconversation.com/world-cup-cr...
theconversation.com
World Cup creates perfect conditions for infectious diseases to spread – here are the biggest threats health experts are watching for
Respiratory diseases like measles and flu pose a much bigger threat to public health for the World Cup than does Ebola.
000
Andres Henao, MD PhD FIDSA @andhen25.bsky.social · 18/05/2026
I am very proud to present the product of 3 years of hard work. The book "Global Health, Climate Change, and Emerging Infectious Diseases" by Springer Nature was finally published online: link.springer.com/book/10.1007... @cudivofid.bsky.social @cudeptofmedicine.bsky.social
241
Reposted by Andres Henao, MD PhD FIDSA
Skye @simplyskye.bsky.social · 07/04/2026
AOC: “This is a threat of genocide & merits removal from office. The President’s mental faculties are collapsing & cannot be trusted. To every individual in the President’s chain of command: You have a duty to refuse illegal orders. That includes carrying out this threat”
Rep. Alexandria Ocasio-Cortez, D-N.Y., attends a news conference in the U.S. Capitol. (Tom Williams/CQ-Roll Call, Inc via Getty Images)
125117313037
Reposted by Andres Henao, MD PhD FIDSA
UW Infectious Disease Fellowship Program @uwidfellowship.bsky.social · 05/03/2026
Chagas’ disease! A review from CID. This zoonotic disease persists through a complex interplay of socioeconomic disparities, cultural practices, and historical inequities that disproportionately affect impoverished rural communities throughout Latin America academic.oup.com/cid/article/... #IDSky
academic.oup.com
State-of-the-Art Review: Chagas Disease—an Enduring Challenge
Chagas disease remains the most significant neglected tropical disease in the Western Hemisphere. In this review, we examine critical aspects of patient ca
151
Reposted by Andres Henao, MD PhD FIDSA
Joseph Marcus @josephmarcusid.medsky.social · 27/02/2026
The most comprehensive Chagas’ disease review I have read in @cidjournal.bsky.social Congratulations and thank you to @andhen25.bsky.social and team on such a useful paper! #IDSky academic.oup.com/cid/article/...
academic.oup.com
State-of-the-Art Review: Chagas Disease—an Enduring Challenge
Chagas disease remains the most significant neglected tropical disease in the Western Hemisphere. In this review, we examine critical aspects of patient ca
1165
Reposted by Andres Henao, MD PhD FIDSA
Greg Folkers @gregfolkers.bsky.social · 24/02/2026
NEJM: Subacute Sclerosing Panencephalitis after Measles Infection bit.ly/4rFkQ8w @nejm.org Get vaccinated.
01610
Reposted by Andres Henao, MD PhD FIDSA
Nathan Kalman-Lamb @nkalamb.bsky.social · 17/02/2026
“I don’t want to be in this place I want to go to my school.” - 7 year old imprisoned by ICE for 70 days in a concentration camp in Texas. Today, after @propublica.org published this story, the camp was raided to confiscate letters from the children. www.propublica.org/article/ice-...
Mia Valentina Paz Faria
A 7-year-old from Venezuela who was living in Austin, Texas 
Detained for 70 days

“I don’t want to be in this place I want to go to my school.”UPDATE: Staff at the ICE concentration camp in Dilley, Texas have begun raiding the dormitories of kids and their parents to confiscate and destroy letters from the children. This is in response to the ace reporting by 
@micarosenberg
 et al for ProPublica:
319120786919
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 30/12/2025
Chronic pulmonary aspergillosis can complicate pulmonary echinococcosis via residual lung cavities. In this review (41 studies, 72 CPA cases), diagnosis relied on radiology/histology, combined surgical–medical therapy led to uniformly favorable outcomes journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
022
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 13/01/2026
Febrile neutropenia still drives heavy carbapenem use due to MDR Gram-negatives. In a cohort of 553 FN episodes, an ML risk model + prior colonisation data could cut meropenem use by ~30% and IEAT from 23% to 9%, supporting personalised EAT. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Towards personalised empirical antibiotic therapy in febrile neutropenia: a theoretical model based on machine learning and prior colonisation with multidrug-resistant gram-negative bacilli – a retros...
Background: Empirical antibiotic therapy (EAT) in febrile neutropenia (FN) remains challenging due to multidrug-resistant (MDR) Gram-negative bacteria, often le...
022
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 14/01/2026
🦠 Rare but severe: necrotizing gingival & sinus infection due to Trichoderma longibrachiatum in an allo-HSCT recipient. Cure achieved with aggressive surgery 🔪 + combination antifungals 💊, including consolidation with rezafungin. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
022
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 12/02/2026
In this systematic review (29 studies), mNGS outperformed culture for spinal infections with broader pathogen detection,higher sensitivity,faster turnaround⏱️ Challenges remain: cost & distinguishing colonization from infection. journals.sagepub.com/doi/full/10....
022
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 14/02/2026
Invasive pulmonary aspergillosis remains a lethal threat in immunocompromised and post-COVID patients 🦠 Advances in PCR, lateral flow assays, and immuno-PET/MRI are reshaping diagnosis, but rising azole resistance demands susceptibility testing journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
022
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 02/02/2026
Peptide-based vaccines are redefining precision immunology, offering safety, specificity,scalable manufacturing. This review explores how bioinformatics-driven epitope design, nanoparticles,& next-gen adjuvants are fighting viral threats 🚀🦠 journals.sagepub.com/doi/full/10....
033
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 25/01/2026
Ticks strike twice 🐜🐜 Fatal Babesia microti/Borrelia burgdorferi coinfection presenting as acute liver failure and shock. Read full case @ journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
022
Andres Henao, MD PhD FIDSA @andhen25.bsky.social · 21/01/2026
Excited to announce our new Seminar on Leprosy just published online in @TheLancet! 🌍 This multicontinental collaboration provides an update on key public health & clinical aspects of leprosy @thelancet.com @cudeptofmedicine.bsky.social @cudivofid.bsky.social www.thelancet.com/journals/lan...
thelancet.com
Leprosy
Leprosy, also known as Hansen's disease, is a curable granulomatous condition caused by Mycobacterium leprae or Mycobacterium lepromatosis, disproportionately affecting impoverished communities across...
1117
Reposted by Andres Henao, MD PhD FIDSA
Joseph Marcus @josephmarcusid.medsky.social · 13/01/2026
@idweek.bsky.social abstracts have just been posted online on @ofidjournal.bsky.social academic.oup.com/ofid/issue/1... #IDSky
academic.oup.com
Volume 13 Issue Supplement_1 | Open Forum Infectious Diseases | Oxford Academic
An official journal of the Infectious Diseases Society of America. Publishes clinical, translational, and basic research findings focusing on the intersection of biomedical science and clinical practi...
084
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 25/12/2025
⚠️ Rising MDR in cUTIs demands new options. Plazomicin shows strong in-vitro activity, synergy with key agents, and favorable outcomes in trials—yet real-world evidence from LMICs is urgently needed 📉📊. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
032
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 24/12/2025
Imidazolopiperazines (KAF156/ganaplacide) show potent activity across blood, liver, and gametocyte stages of Plasmodium 🦟💊—a promising path forward as antimalarial resistance rises. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
032
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 19/12/2025
📊 New study from Teso, Uganda: Among 1009 TB patients, overall treatment success was 91.9%. Females had higher success, while age >49 and HIV infection lowered success. Early screening, preventive therapy, and peer support are key to improving outcomes. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
032
Reposted by Andres Henao, MD PhD FIDSA
CU Anschutz Department of Medicine @cudeptofmedicine.bsky.social · 19/12/2025
Our Faculty recently took part in a pilot Spanish case conference in collaboration with UCLA and the University of the Amazonia (Peru), focused on tropical medicine—with English translation included. A great opportunity to learn and practice Spanish! Thanks to @andhen25.bsky.social. 🌟
031
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 19/12/2025
🧬 Unusual infection: M. luteus, normally a skin commensal, triggered prosthetic valve endocarditis in an immunocompetent woman. 8 weeks of IV vancomycin led to full recovery. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Micrococcus luteus-induced prosthetic valve infective endocarditis in an immunocompetent patient: a case report from India - Ritvik Sajan, Sreekrishnan Trikkur Parasuraman, Akhil Arun, 2025
Micrococcus luteus (M. luteus) is a Gram-positive microorganism that typically dwells in environments such as soil, water, and human skin, hence, entitling it a...
022
Reposted by Andres Henao, MD PhD FIDSA
Joseph Marcus @josephmarcusid.medsky.social · 12/12/2025
Travel medicine clinic does not have many travelers to Switzerland 🇨🇭 -70yo 🇺🇸 traveler to 🇨🇭 died from Tick-Borne Encephalitis after 🥾 in Alps -12th case in 🇺🇸 traveler since 2000 -TBE vaccine 💉 recommended for travelers to Europe/Asia with⬆️ tick exposures #IDSky wwwnc.cdc.gov/eid/article/...
wwwnc.cdc.gov
Fatal Tick-Borne Encephalitis in Unvaccinated Traveler from the United States to Switzerland, 2022
Fatal Tick-Borne Encephalitis in Traveler
1124
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 02/10/2025
📊 HIV from injection drug use is climbing (2016–2022). PrEP uptake in PWID remains critically low. Call to action: integrate ID + addiction care, expand low-barrier services, implement LA-PrEP, and fight stigma through policy + education. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
043
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 02/10/2025
ED study in Japan: Relaxation of COVID-19 IPC practices led to a surge in virus-related exacerbations of COPD (7.7%→52.5%) & asthma (39.7%→66.7%). Reinforcing viral prevention is key in chronic airway disease care. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
011
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 15/10/2025
Dolutegravir/lamivudine improved quality of life, treatment acceptability, and symptom burden in PLWH over 6 months (French multicenter study, n=260). Gains appeared by month 1 and persisted. Monitoring discontinuations—especially among women—remains key. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
022
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 18/10/2025
A systematic review (2003–2023) shows live attenuated (LAIV) and inactivated (IIV) influenza vaccines protect children/adolescents equally well (~50% VE). Post-2017 LAIV strain updates restored H1N1 protection and improved efficacy vs influenza B. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
032
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 30/10/2025
P. aeruginosa is the archetype of adaptive resistance—porins close, pumps activate, enzymes evolve. New β-lactam/β-lactamase inhibitor combos and cefiderocol offer treatment options. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
022
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 02/11/2025
Novel entomo-virological tools, such as honey-baited traps preserving mosquito-expectorated RNA, are reshaping arbovirus monitoring. Integrating these with genomic surveillance can bridge field ecology and molecular epidemiology. 🔬🦟https://journals.sagepub.com/doi/full/10.1177/20499361251391261
032
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 19/11/2025
Recurrent UTIs remain a major burden, and new guidance is steering care toward non-antibiotic prevention—behavioural measures, topical oestrogen, methenamine hippurate, and intravesical HA/CS 💡💊💧 Read this review for more 📘✨ journals.sagepub.com/doi/full/10....
143
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 25/11/2025
AI-driven models are showing clear promise in improving HIV/TB detection and management in Nigeria, where immunosuppression drives disproportionate TB risk. Strengthening technical capacity will be essential for translating this potential into practice. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
022
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 11/12/2025
Antipseudomonal beta lactams yielded outcomes similar to cefazolin/oxacillin in this study of of MSSA bacteremia.However there were more complicated infections in the SOC arm.These data may inform antibiotic choices when broad coverage is needed. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
022
Reposted by Andres Henao, MD PhD FIDSA
CU Anschutz Infectious Diseases @cudivofid.bsky.social · 05/12/2025
Our division is thrilled to welcome a full cohort of talented ID fellows next year! Join us in celebrating Drs. Caroline Bashour, Shanmukha Priya Peddireddy, Gavi Roda, and Sum Park Sarmadi. We can't wait for them to join our team! 🌟👏
141
Reposted by Andres Henao, MD PhD FIDSA
The Lancet @thelancet.com · 04/12/2025
Review—"Health care in the USA: money has become the mission" 👇 spkl.io/63325Agg1T
Figure showing UnitedHealthcare's health insurance revenues from private and public sources, USA, 2010–24. Copyright: 2025 Elsevier Ltd. All rights are reserved.
189
Reposted by Andres Henao, MD PhD FIDSA
Madhu Pai, MD, PhD @madhupai.bsky.social · 02/12/2025
Online Postgraduate Diploma in Tropical Medicine and Hygiene (DTM&H), the longest-standing course of its type in Africa www.wits.ac.za/course-finde...
072
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 30/11/2025
Check out highlights from the 2025 Group B Strep in Pregnancy & Babies Conference: new data spanning antimicrobial stewardship, epidemiology, diagnostics, prevention policies, virulence profiling, and next-gen sequencing for neonatal GBS. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Proceedings from Group B Strep in Pregnancy & Babies Conference, Wednesday, May 14th 2025, virtual meeting, 2025
022
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 23/11/2025
Data from 89 patients suggest that follow-up FDG-PET/CT can guide decisions in focal infections but is most informative when bacteremia is gram-positive or clinical status deteriorates. Findings support targeted rather than routine use. 🔍🦠📊 journals.sagepub.com/doi/full/10....
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
022
Reposted by Andres Henao, MD PhD FIDSA
Julio C. Zuniga-Moya @julioczuniga1.bsky.social · 23/11/2025
pubmed.ncbi.nlm.nih.gov/41251369/
pubmed.ncbi.nlm.nih.gov
Insights into current coccidioidomycosis therapeutic pathways - PubMed
Coccidioidomycosis is a systemic fungal infection caused by <i>Coccidioides immitis</i> and <i>Coccidioides posadasii</i>, which are endemic to the Southwestern United States and parts of Mexico, Central, and South America. While oral fluconazole is widely recommended as first-line therapy, treatmen …
011
Reposted by Andres Henao, MD PhD FIDSA
IDSA @idsainfo.bsky.social · 21/11/2025
Decades of rigorous and scientifically sound research have proven that vaccines do not cause autism. CDC’s decision to change language on its website reversing that finding is reckless & harmful. Our statement w/ @hivma.bsky.social, APIC, @sheaepi.bsky.social & @sidpharm.bsky.social: bit.ly/3XEc0KH
311765
Andres Henao, MD PhD FIDSA @andhen25.bsky.social · 20/11/2025
FIRST first-author pub for Brent is OUT! “Insights into Current Coccidioidomycosis Therapeutic Pathways” now in @asm.org Fluconazole dominates, but switches are common in severe cases. Proud mentor moment! 🎉 @cudeptofmedicine.bsky.social journals.asm.org/doi/10.1128/...
journals.asm.org
Insights into current coccidioidomycosis therapeutic pathways | Antimicrobial Agents and Chemotherapy
Coccidioidomycosis (“San Joaquin Valley Fever”) is a systemic fungal infection caused by the dimorphic fungi Coccidioides immitis and Coccidioides posadasii, which are endemic to regions of the Southw...
082
Andres Henao, MD PhD FIDSA @andhen25.bsky.social · 20/11/2025
Thrilled to have delivered the inaugural Sirus Naraqi, MD Memorial Lecture at @uicpublichealth.bsky.social DOM Grand Rounds this week! Topic: Chagas & NTDs – in the US Huge thanks to my friend and colleague @mbrito05.bsky.social for the invite! #GlobalHealth @cudeptofmedicine.bsky.social
061
Reposted by Andres Henao, MD PhD FIDSA
Paul Sax @paulsaxmd.bsky.social · 18/11/2025
Tested two different AI products with some medical advice. Prompt: "When people get shingles again, is it usually in the same location?" OpenEvidence: Home run. ChatGPT: Big whiff. Plus, a chance to support the shingles vaccine -- so important! #IDSky blogs.jwatch.org/hiv-id-obser...
blogs.jwatch.org
When AI Gets the Medical Advice Wrong — and Right
A journalist recently reached out to ask about the shingles vaccine. We mostly talked through the usual topics — how common shingles is, why the vaccine works so well, and side effects. Plus, the whol...
1155
Reposted by Andres Henao, MD PhD FIDSA
The Washington Post @washingtonpost.com · 17/11/2025
A new study found the Trump administration’s cuts to NIH grants disrupted more than 380 clinical trials, affecting over 74,000 participants. The cuts disproportionately impacted trials on infectious diseases and minority communities.
washingtonpost.com
Federal cuts upended clinical trials. A new study reveals the toll.
Grants for 383 clinical trials were terminated and the funding disruptions affected more than 74,000 trial participants, according to new research.
912695
Reposted by Andres Henao, MD PhD FIDSA
Alfred Luk @alukmd.bsky.social · 15/11/2025
Great resource for parasitic testing options from @astmh.bsky.social while CDC services are offline.
astmh.org
ASTMH - Non-CDC Options for Molecular and Serologic Testing for Parasitic Diseases
Posted 19 March 2025
0153
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 15/11/2025
Antibiotics disrupt gut/airway microbiomes across ages 🦠, amplifying both targeted and background resistance genes 🧬. Recovery remains especially poor in children 👶 journals.sagepub.com/doi/full/10....
022
Reposted by Andres Henao, MD PhD FIDSA
Therapeutic Advances in Infectious Disease @tainfdis.bsky.social · 11/11/2025
A multistep UTI-focused stewardship initiative reduced unnecessary treatment of asymptomatic presentations by 12% & improved adherence to UTI management guidelines. journals.sagepub.com/doi/full/10....
journals.sagepub.com
Impact of a multistep urinary tract infection-focused disease state stewardship initiative on the treatment of asymptomatic urinary presentations: a retrospective cohort study - Christian Tyler Pitcoc...
Background: Asymptomatic bacteriuria (ASB) is often overtreated, risking patient harm through unnecessary antimicrobial use and fostering antimicrobial resistan...
022
Reposted by Andres Henao, MD PhD FIDSA
Madhu Pai, MD, PhD @madhupai.bsky.social · 10/11/2025
A global health journal with an all-female executive leadership team! ✨ @plosglobalpublichealth.org continues to push the boundaries with today's announcement of Prof. Manuela De Allegri joining @ckyobutungi.bsky.social as a co-editor-in-chief & @juliarobinson.bsky.social as Exec Editor
2409
Andres Henao, MD PhD FIDSA @andhen25.bsky.social · 11/11/2025
Love to share our fruitful collaboration with our Peruvian scientists in the Amazon #GlobalHealth @cudivofid.bsky.social @cudeptofmedicine.bsky.social @annalsofim.bsky.social www.acpjournals.org/doi/10.7326/...
acpjournals.org
Polymerase Chain Reaction–Confirmed Oropouche Virus Disease in Loreto, Perú: A Case Series From December 2023 Through September 2024 | Annals of Internal Medicine
032